MAPK3 and breast carcinoma: Moreover, CCL28 has been shown to drive the growth and metastatic spread of breast cancer by activating the MAPK/ERK1/2 pathway, while the CXCL12-CXCR4 axis supports cancer cell proliferation, relying on the MAPK pathway for its effects [28].